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Abstract
Background: NHS Health Check is a national cardiovascular disease (CVD) risk assessment programme for 40–74 year olds
in England, in which practitioners should assess and communicate CVD risk, supported by appropriate risk-management
advice and goal-setting. This requires effective communication, to equip patients with knowledge and intention to act.
Currently, the QRISK®2 10-year CVD risk score is most common way in which CVD risk is estimated. Newer tools, such as
JBS3, allow manipulation of risk factors and can demonstrate the impact of positive actions. However, the use, and relative
value, of these tools within CVD risk communication is unknown. We will explore practitioner and patient CVD risk
perceptions when using QRISK®2 or JBS3, the associated advice or treatment offered by the practitioner, and patients’
responses.
Methods: RIsk COmmunication in NHS Health Check (RICO) is a qualitative study with quantitative process evaluation.
Twelve general practices in the West Midlands of England will be randomised to one of two groups: usual practice, in which
practitioners use QRISK®2 to assess and communicate CVD risk; intervention, in which practitioners use JBS3. Twenty Health
Checks per practice will be video-recorded (n= 240, 120 per group), with patients stratified by age, gender and ethnicity.
Post-Health Check, video-stimulated recall (VSR) interviews will be conducted with 48 patients (n = 24 per group) and all
practitioners (n= 12–18), using video excerpts to enhance participant recall/reflection. Patient medical record reviews will
detect health-protective actions in the first 12-weeks following a Health Check (e.g., lifestyle referrals, statin prescription). Risk
communication, patient response and intentions for health-protective behaviours in each group will be explored through
thematic analysis of video-recorded Health Checks (using Protection Motivation Theory as a framework) and VSR interviews.
Process evaluation will include between-group comparisons of quantitatively coded Health Check content and post-Health
Check patient outcomes. Finally, 10 patients with the most positive intentions or behaviours will be selected for case study
analysis (using all data sources).
Discussion: This study will produce novel insights about the utility of QRISK®2 and JBS3 to promote patient and practitioner
understanding and perception of CVD risk and associated implications for patient intentions with respect to health-
protective behaviours (and underlying mechanisms). Recommendations for practice will be developed.
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Background
Cardiovascular risk communication in NHS Health Check
Cardiovascular disease (CVD) is the UK’s leading cause
of mortality, accounting for 27% of all deaths [1]. The
National Health Service (NHS) Health Check [2] is a
strategically important national CVD risk assessment
programme for adults in England aged 40–74 without
certain cardiovascular-related diseases. Initiated in 2009,
NHS Health Checks represent a considerable public in-
vestment. However, use of general health checks to reduce
population CVD or CVD risk is much debated [3–8]. In
addition to a relative dearth of evidence to support the
longer-term clinical value of general health checks, or spe-
cifically relating to NHS Health Checks, little is known
about the nature of Health Check consultations. Consulta-
tions should involve a practitioner (usually a Practice
Nurse (PN) or Health Care Assistant (HCA)) assessing
and then communicating the patient’s CVD risk to them,
supported by appropriate advice and goal setting. This
may range from basic lifestyle advice to referrals to the GP
for medication or to relevant services (e.g., smoking cessa-
tion; dietetic). However, insights regarding exactly what
happens during Health Checks are limited to retrospective
qualitative data [9].
Practitioner-patient interactions are complex [10] and
communicating risk is challenging [11]. For Health
Checks to promote health-protective behaviours that re-
duce CVD risk, practitioners need to understand the risk
information and be able to communicate it effectively
such that patients leave the consultation with the know-
ledge and intention to act. A review of 70 risk-scoring
methods concluded that there is no single ‘correct’ ap-
proach, but that this will depend on individual patient’s
preferences and understanding, which, in turn, may dif-
fer with education status, numeracy, and personality
traits, such as optimism [12]. The patients’ emotional re-
sponse to the communication of risk, how and by whom
the information is conveyed, presentation of risk and the
influence on health behaviour, differ greatly between pa-
tients [13–16]. Poor communication of risk can cause
patients anxiety and reduce confidence in health profes-
sionals [17], or may result in the perception that action
is futile, but if delivered effectively, it can enhance know-
ledge and decision making about treatment, and can em-
power and create autonomy [18].
To date, there is insufficient evidence to know the na-
ture and adequacy of CVD risk communication in NHS
Health Checks. The standard CVD risk score for use in
Health Checks is QRISK®2, a percentage risk of a CVD
event in the next 10 years, which is integrated within in
general practice medical record software. QRISK®2 has
two main limitations. First, the score depends heavily on
age and gender (underestimating risk in younger adults/
women) and cannot account for risk from other diseases
as effectively as long-term estimates [19]. Second, retro-
spective interview data show limited practitioner/pa-
tient understanding of percentage CVD risk [9, 20,
21], that practitioners find it difficult to explain per-
centage CVD risk [14, 22–24] and, in turn, patients
may be unable to recall being provided with a risk
score or find it confusing [9]. Further, representing per-
centage risk over the next 10 years (absolute risk) can be
falsely reassuring [25, 26]. This is particularly problematic
for individuals with low-to-moderate CVD risk who have
a number of modifiable risk factors, such as smoking,
obesity and hypertension [27]. These limitations have
sparked interest in alternative metrics, such as heart age
[3, 28–30] and lifetime risk [19], and use of multiple visual
displays to present them [11].
JBS3 was launched in 2014 with a primary focus on life-
time risk [19]. It uses various visual displays (e.g., graphs of
risk trajectory across life course; smiley face (‘Cates’) plots to
illustrate percentage risk) and other metrics, such as Heart
Age, and allows practitioners to manipulate and thus show
the effects on lifetime risk trajectory of risk factor modifica-
tion (e.g., smoking cessation) [19]. The potential advantages
of JBS3 over QRISK®2 include: (i) measurement of lifetime
risk, which is less dependent on age and gender; (ii) lifetime
risk takes into account both risk from CVD and competing
diseases; (iii) multiple ways in which risk information is pre-
sented could accommodate the needs and preferences of a
range of patients and facilitate practitioner communication
[11, 28]; (iv) ability to manipulate risk factors to demonstrate
the effects of risk factor modification, which could facilitate
discussion about lifestyle change or interventions; (v) heart
age combines absolute risk and relative CVD risk in a way
that easier to understand than percentage CVD risk [3].
In summary, we lack understanding of how risk is
communicated by practitioners, and understood and
used by patients in NHS Health Checks, but we do rec-
ognise limitations of percentage risk scores, such as
those presented by QRISK®2 [20, 21]. Further, we can
see the potential advantages of conveying risk informa-
tion using more flexible and interactive platforms such
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as JBS3. Unless these potential advantages are evidenced
to support these more adaptable and comprehensive risk
communication platform, implementation of JBS3
through incorporation into general practice software sys-
tems, is unlikely.
Aims and objectives
RIsk COmmunication in NHS Health Check (RICO) is a
qualitative study and quantitative process evaluation that
aims to explore practitioner and patient perceptions and
understanding of CVD risk when using the JBS3 lifetime
risk calculator or the QRISK®2 10-year risk calculator,
the associated advice or treatment offered by the practi-
tioner and the response of the patient. Specific study ob-
jectives are to:
1. Explore how practitioners use QRISK®2 and JBS3 to
communicate CVD risk in the consultation
2. Explore how patients respond to the risk
information
3. Explore how QRISK®2 and JBS3 promote patient
and practitioner understanding and perception of
CVD risk
4. Explore patient intentions with respect to health-
protective behaviours
5. Explore mechanisms by which intentions for
health-protective behaviours are elicited
6. Make recommendations regarding use of QRISK®2
or JBS3 in Health Checks.
Theoretical basis
Given the complexity of practitioner-patient interactions [31,
32] and the translation of risk information into health-pro-
tective behaviour [33], to ensure a comprehensive enquiry
about the relative values of JBS3 and QRISK2, we have used
a theoretical framework based on the revised Protection Mo-
tivation Theory (PMT) [34]. Within the PMT, ‘protection
motivation’ refers to the intention to undertake
health-protective behaviour resulting from the cogni-
tive appraisals (or internal assessments); CVD risk
communication could be a key source of information
feeding into such appraisals (Fig. 1).
PMT is informed by fear-drive models, which recog-
nise that behaviour change can be prompted by
fear-inducing communications that motivate action to
reduce the perceived threat (or risk) [33, 35]. However,
protection motivation is influenced by two cognitive ap-
praisals; appraisals of the threat (risk of CVD) and
coping (consequences undertaking positive behaviour
change). Threat appraisal evaluates maladaptive re-
sponses; i.e., not initiating positive behaviours in
response to recognising an elevated CVD risk. This con-
siders the source of the threat (i.e., practitioner/Health
Check), intrinsic rewards (e.g., enjoyment associated
with health risk behaviour) and extrinsic rewards (e.g.,
social approval), and the perception of the threat (per-
ceived severity and personal vulnerability). Coping ap-
praisal evaluates the adaptive response to cope with
the threat (i.e., CVD risk), and considers the likeli-
hood that positive behaviour change (adaptive re-
sponse) will reduce their risk (response efficacy), their
own ability to make the necessary changes (self-effi-
cacy), and the burdens of, or barriers to, making the
change (response costs) [33, 34, 36, 37]. Threat and
coping appraisals are influenced by both environmen-
tal aspects (e.g., persuasive communication and obser-
vational learning) and intrapersonal variables (e.g.,
personality and feedback from prior experience of
both positive (adaptive) and negative (maladaptive)
behaviours) [33]. In the context of this study, PMT
underlines the key role that practitioners have in pro-
viding information on CVD risk (vulnerability) and
incorporating a patient’s beliefs, priorities and experi-
ences into strategies to reduce this risk so that
Fig. 1 Protection Motivation Theory model adapted to proposed study context (adapted from [33, 35])
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patients feel they can achieve adaptive behaviours [34]
and subsequent health outcomes.
PMT is particularly pertinent to study the relative
merits of different CVD risk calculators and the mecha-
nisms by which they might promote positive behaviour
change for several reasons. First, it was initially devel-
oped to examine intention to adopt behaviours relating
to disease prevention [38]. Second, it does not assume
rationality in behaviour choices [33, 39]; that is, people
will undertake unhealthy behaviours as they serve other
purposes, for example, enjoyment or social integration.
Third, its components have been associated with
(intention for) behaviour change in relevant contexts
(e.g., smoking cessation, exercise) [34, 36] and, fourth, it
provides an understanding of why attitudes and behav-
iour can change when people are confronted with
threats (i.e., the mechanisms) [33].
Methods/design
Design and setting
This qualitative study, which includes a quantitative
process evaluation, will be undertaken in 12 general
practices in the West Midlands that already deliver
NHS Health Checks. Six practice pairs, approxi-
mately matched on practice size and deprivation, will
be randomly assigned to one of two groups:
QRISK®2 (usual practice) - practitioners continue to
use QRISK®2 to communicate CVD risk during
Health Checks; JBS3 (intervention) - practitioners
use the JBS3 CVD risk calculator following brief
training about the platform, but no training will be
provided about risk communication. Participating prac-
tices will video-record their NHS Health Checks using the
allocated CVD risk calculator over until 20 useable consul-
tations are recorded. As summarised in Fig. 2 and detailed
below, data collection will comprise: (1) Video-recording
NHS Health Check consultations; (2) Post-consultation
video-stimulated recall (VSR) interviews with patients and
practitioners within 2 weeks, using excerpts from recorded
health checks to facilitate recall and reflection; (3) Patient
medical record reviews 12-weeks post-Health Check to de-
termine subsequent action (e.g., GP appointment, lifestyle
referral, statin prescription).
Sample
General practices
General practices that meet the following criteria will be
recruited: a) deliver NHS Health Checks; b) already use
the QRISK®2 percentage risk score in Health Checks;
currently (or willing to) deliver Health Checks in specific
clinics to facilitate data collection; c) are signed up to
the ‘incentive scheme’ implemented by the Clinical
Fig. 2 Flow diagram of study processes
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Research Network (CRN) to ensure the GP practice is
‘research ready’; d) are willing to participate.
General practices will be stratified using data on practice
list size and deprivation level of the practice location [40]
to provide a proxy measure of typical socio-economic sta-
tus of the practice population (Table 1).
Patients
The patient population will be those eligible for NHS
Health Checks based on national criteria. These exclude
people who: a) are outside the target age range (40–74
years); b) have existing diagnoses for certain cardiovascu-
lar-related chronic conditions; c) are taking statins; d) have
had a NHS Health Check in the last 5 years; e) are known
to be at high risk (≥20% 10-year CVD risk score) [41] .
Practitioners
Participating practitioners will be the healthcare profes-
sionals who usually deliver Health Checks in participating
practices and who are willing to participate; usually one to
two Practice Nurses (PN) or Health Care Assistants
(HCA) per practice (n = 12–24).
Recruitment
Practice sampling
The CRN will facilitate practice sampling. Briefly, this will in-
volve an initial email to ‘research ready’ practices inviting
expressions of interest. To identify willing and eligible prac-
tices, those expressing interest will be followed up with tele-
phone calls and visits as appropriate. Practice participation
will be incentivised through financial reimbursement of ser-
vice support costs and remuneration for completing all parts
of the study. Following practice-level consent, practice pairs
matched on size and deprivation (Table 1), will be randomly
assigned to the QRISK®2 or JBS3 group using a random
number generator in MS Excel. After randomisation, the
research team will undertake an initiation meeting at the
practices to provide further information and basic training
for staff involved.
Patient and practitioner sampling
There will be three levels of patient sampling.
1) Total sample (n = 240): To achieve the 144 recorded
consultations suitable for qualitative analysis (12 per
practice allowing for non-attendances and consultations
with no/minimal discussion of CVD risk), Health Check
clinics would be recorded until 20 recordings per practice
(240 total) have been achieved. In each practice, searches of
the patient database will identify the cohort of eligible pa-
tients who will be stratified according to gender, age and eth-
nicity to ensure representation from different demographic
groups (Table 2).
2) Qualitative analysis (n = 144): Video recordings will
be screened within 48 h of filming. This will involve quan-
titative coding of the content of the consultation to iden-
tify those suitable for qualitative analysis (12 per practice)
and VSR interview (4 per practice). Where risk is not dis-
cussed by patient or practitioner, the patient’s data would
not be used for either.
3) VSR interviews (n = 48): VSR interviews will be con-
ducted with 48 patients (24 per group) sampled from
the 144 recorded Health Checks, stratified by gender,
age and CVD risk (Table 3).
The proposed total of 144 recorded consultations (12
per practice) with 48 patient VSR interviews and 18
practitioner VSR interviews, is comparable with other
studies using audio-recording of similar consultations to
explore CVD risk communication in patients with psor-
iasis (n = 130 in 10 practices [42]) and the number of in-
terviews in VSR studies (n = 9–39 [43]).
All practitioners who will deliver the video-recorded
Health Check clinics will be asked to participate in VSR
interviews.
Groups
QRISK®2 group (usual practice): Practitioners will deliver
Health Checks as usual, using the QRISK®2 risk calcula-
tor as per usual practice.
JBS3 group (intervention): Practitioners will deliver
Health Checks using the JBS3 risk calculator. An
Table 1 Stratified sampling of six practices per group based on
deprivation and list size
Deprivation
Practice list size Most deprived 50% Least deprived 50%
Small-Medium (< 8000) 2 QRISK®2; 2 JBS3 2 QRISK®2; 2 JBS3
Large (≥8000) 1 QRISK®2; 1 JBS3 1 QRISK®2; 1 JBS3
Table 2 Stratified sampling of the 20 patients per practice to
be invited for recorded Health Checks
Gender
Female Male
Age (yr) 40–54 yr 4 (3 WBRI/1 BAME) 4 (3 WBRI/1 BAME)
55–64 yr 3 (2 WBRI/1 BAME) 3 (2 WBRI/1 BAME)
65–74 yr 3 (2 WBRI/1 BAME) 3 (2 WBRI/1 BAME)
WBRI, White British; BAME, Black, Asian, Minority Ethnic
Table 3 Example of stratified sampling of VSR patient
interviews per group based on age, CVD risk and gender
CVD Riska
Low (<10%) Medium-High (≥10%)
Age (yr) 40–54 yr 2 m / 2 f 2 m / 2 f
55–64 yr 2 m / 2 f 2 m / 2 f
65–74 yr 2 m / 2 f 2 m / 2 f
aQRISK percentage 10-year risk would be used for stratification purposes for
consistency across both groups
Gidlow et al. BMC Family Practice           (2019) 20:11 Page 5 of 10
introductory session with practitioners will establish the
requirements to: avoid using QRISK®2 to communicate
CVD risk; use the first two ‘output’ screens as a minimum
(Heart Age and Survival Age); show the effects of inter-
vention through modifying risk scores (e.g., lowering
blood pressure, smoking cessation); practice with JBS3 in
at least two Health Checks prior to video-recorded clinics.
Data collection procedures
Video-recorded health checks
Digital camcorders will be positioned in the Health
Check clinic rooms to provide an audio-visual record of
consultations. Informed by Patient Public Involvement
(PPI) and pilot work, cameras will be positioned to cap-
ture both patient and practitioner, but prioritising the
view of the patient. Video recordings will be screened
(during quantitative coding). If there is no discussion of
CVD risk, this will be noted, and the file retained. For
consultations that involve discussion of CVD risk, the
audio-record will be separated from the visual (using
Adobe Premiere Pro) for transcription and qualitative
analysis (n = 12 per practice; 144 total).
Semi-structured VSR interviews with patients and
practitioners
Semi-structured one-to-one VSR interviews with patients
will be arranged within the 2 weeks following their Health
Check; for practitioners, VSR interviews will be within 2
weeks of their final recorded Health Check. After each
clinic, recorded Heath Checks will be watched to identify
sections of the consultation to use in VSR interviews that
relate to discussion of the CVD risk score, modification of
the risk score, and practitioner advice, recommendations
and interventions. For practitioner VSR interviews, video
excerpts will be taken from the consultations with patients
also selected for VSR interviews. The semi-structured
VSR interviews will follow a pre-piloted process and topic
guide (Additional file 1: Table S1), with slight variation de-
pending on whether the patient/practitioner are in the
QRISK®2 or JBS3 group. All VSR interviews will be
audio-recorded and transcribed verbatim for analysis.
Patient medical record review
Data from the 12weeks following the Health Check will be
extracted from patient medical records to identify any subse-
quent activity. This will be used to identify any subsequent
recorded actions or interventions (e.g., GP appointment, life-
style referral, or statin prescription).
Patient and public involvement
Patient and Public Involvement (PPI) activities informed
study development and will continue to its completion.
Three PPI strategies have been used. First, we have en-
gaged with Patient Participation Groups (PPG) by
attending PPG meetings at three general practices on two
occasions to gather opinion on the study concept and
overall design, and subsequently, the methods and proto-
cols. One PPG facilitated the completion of four mock
Health Checks (with the Practice Nurse and four PPG
members) to allow testing of protocols including camera
placement, video-recording quality, participant consent
and debrief processes, development of the quantitative
and qualitative coding frameworks, post-processing of
video for VSR excerpts and development of the VSR topic
guide and protocols. Second, two patient representatives
sit on the Study Steering Committee for ongoing involve-
ment of patients in project management. Third, a virtual
study patient group has been established using a closed
Facebook group. This has allowed engagement with many
patients and public (current membership ~ 295) who have
provided rapid feedback on a range of issues (e.g., consent
forms, participant information sheets, camera placement).
Data analysis
Qualitative and quantitative data will be analysed to in-
form the quantitative process evaluation, qualitative out-
comes and case studies (Fig. 2). The processes are
summarised by data source.
Qualitative data - recorded health check consultations
Qualitative data will be analysed using thematic analysis,
following the six stage process described by Braun and
Clarke [44] (Table 4). Health Check consultation data will
be analysed deductively. A coding template will be devel-
oped based around the PMT (Fig. 1). Each consultation
video and associated transcript will be uploaded to NVivo
for analysis, using the visual information from the videos
for additional context (see Additional file 2: Table S2 which
gives examples of how behaviours can be used to deter-
mine level of engagement). Analysis will be completed sep-
arately for consultations in the QRISK®2 and JBS3 groups
for comparison. This will allow interpretation of how
QRISK®2 and JBS3 are used to communicate risk in the
context of PMT factors (e.g., verbal persuasion, influencing
patient prior beliefs and priorities; Obj.1) and how patients
respond (Obj.2), which will reflect the nature of their ap-
praisal (threat/coping) within the consultation. Both will
allow inferences about the mechanisms at work in consul-
tations that appear more/less successful (Obj. 5).
Qualitative data - semi-structured VSR interviews with
patients and practitioners
Patient VSR interview transcripts will be analysed using
inductive thematic analysis, where codes and themes are
generated from data based on individual reflections, per-
ceptions and experiences (Table 4). This will be com-
pleted separately for QRISK®2 and JBS3 groups for
comparison. The resulting thematic map for each group
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will provide insight into patient perceptions and under-
standing of CVD risk (Obj. 3), with video-stimulated re-
flections on that experience, and further reflections on
their thoughts, feelings and intentions to undertake
health-protective behaviour following the Health Check
(Obj. 4). Data will also allow inferences about the under-
lying mechanisms (Obj. 5).
Similarly, inductive thematic analysis will be used to
analyse practitioner VSR interview transcripts, separately
for QRISK®2 and JBS3 groups. The resulting thematic
map for each group will provide insight into their percep-
tions and understanding of CVD risk (Obj. 3), with
video-stimulated reflections on aspects such as how they
communicate risk in consultations, their use of the calcu-
lator, the types of advice they offer, patient responses (Obj.
4), allowing inferences about the underlying mechanisms
(Obj. 5).
Quantitative - content of health check consultations
The content of the recorded consultations will be charac-
terised using a coding framework that involves second-by-
second coding of Health Check content. The framework
comprises 36 items grouped in to six categories (patient--
practitioner communication, general Health Check pro-
cesses, risk dialogue, CVD risk factors, lifestyle interventions,
medical interventions). The resulting data will provide aggre-
gate indicators for each consultation to allow between-group
comparisons (e.g., proportion of Health Check considered
practitioner- or patient-dominated; proportion of time dis-
cussing risk; proportion of time discussing intervention/
changes; number of times the practitioner manipulated the
risk score to illustrate amenability of risk to change).
The development of the coding process and guide was
iterative. Four “mock” Health Checks were undertaken
by practitioners and PPI volunteers. These were
video-recorded and two researchers (LC; NE) coded the
consultations by consensus to reach consistency in ap-
proach. A third researcher (VR) then coded all four
consultations independently. Intraclass Correlation Coef-
ficients (ICCs) were calculated and demonstrated excel-
lent inter-rater reliability (ICCs ranged from .968 to
.995). The resulting framework will be refined during a
training/checking phase with study data, whereby an add-
itional four recorded Health Checks (2% of total) will
again be independently coded by two researchers and
inter-rater agreement assessed. Once finalised, two re-
searchers (LC; VR) will code the remaining Health Check
recordings independently (118 each). For every 20 coded
consultations (8% of total), two would be subject to inde-
pendent verification (independent coding and calculation
of ICCs). This will mitigate the risk of coder drift through-
out the study and provide independent verification of 10%
of consultations overall.
A between subjects t-test or non-parametric equivalent
will be used for between-group comparisons of key out-
comes for Health Check content (e.g., proportion of time
spent discussing CVD risk). To explore possible cohort ef-
fects within the data, ICCs will be calculated (i.e., to exam-
ine possible clustering within practices). Multi-level
modelling is not appropriate; the study is designed to
allow for novel qualitative enquiry and is not powered for
multi-level statistical analysis.
Quantitative – Patient medical record review
Data from patient medical records will be tabulated for
an exploratory descriptive comparison of the two
groups. The primary purpose will be to provide add-
itional context to qualitative data, particularly the VSR
interview and case study analysis (see below).
Between-group comparisons will be explored as above.
Within-case analysis
A subsample of 10 patients who demonstrate the most
positive intentions and/or behaviours to reduce CVD
risk following the Health Check will be selected for case
study analysis, drawing on all data for each patient. The
Table 4 Process of Thematic Analysis (adapted from [45])
Phase Summary
Phase
1
Familiarisation Analysis will start with a period of familiarisation involving watching and re-watching the video-recorded consult-
ation (or listening to audio-records in the cases of interviews), noting initial thoughts in the transcript
Phase
2
Initial coding For deductive analysis, codes from the PMT template will be applied to the transcript independently by two
researchers; for inductive analysis, codes will be generated based on interesting features, and recurrent patterns, in
the data. For both inductive and deductive analysis, the researchers will then go back through and check their own
codes, before discussion to verify and agree final codes.
Phase
3
Searching for themes Agreed codes will be collated into potential themes, gathering all data relevant to each potential theme.
Phase
4
Reviewing themes Constant comparison will be used to check themes by revisiting data to ensure they are representative, and then
generating a thematic ‘map’ of the analysis.
Phase
5
Defining and naming
themes
Ongoing analysis to refine the specifics of each theme, and the overall story, generating clear definitions and names
for each theme
Phase
6
Reporting Illustrative extracts will be selected to include in a narrative that tells the overall story.
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aim is to further explore apparent mechanisms by which
the risk calculators may lead to changes in patient or
practitioner behaviour (Obj. 5). A coding framework for
deductive analysis of qualitative data based on potential
mechanisms of eliciting health-protective intentions/be-
haviours will be generated from findings in recorded
Health Checks, and VSR patient and practitioner inter-
views, and applied to qualitative data in each case study
(Health Check, and patient and practitioner VSR inter-
views). The quantitative data on Health Check content
and subsequent actions would be used to provide a basic
profile for each patient to aid interpretation.
Sample size
A priori determination of sample sizes for qualitative re-
search is a point of contention [45, 46]. For the present
study, it was necessary to estimate requirements for the
patient VSR interviews and use this to inform the total
number of recorded Health Checks required per practice.
As summarised in Table 3, 48 VSR patient interviews (24
per group, 4 per practice) will allow patient sampling
stratified by gender, age and CVD risk, and provide a sam-
ple size that compares favourably with studies using VSR
or audio-recordings of primary care consultations (ran-
ging from n = 9–44 [42, 43]). These 48 recorded Health
Checks will be selected (with stratification) from 144 (72
per group, 12 per practice) that are subject to deductive
qualitative analysis; i.e., 12 per practice was deemed suffi-
cient to allow stratified sampling of four patients per prac-
tice. To obtain the 144 recorded Health Checks that are
suitable for qualitative analysis, we will aim to record 240
(120 per group, 20 per practice). This oversampling will
serve two purposes. First, it will allow for exclusions due to
non-attendance, technical issues and Health Checks that
contain little or no discussion of CVD risk. Second, with 120
consultations per group, using a between subjects t-test with
a two-tailed probability and alpha of .05, we will have statis-
tical power of at least .8 to detect a small to medium effect
(Cohen’s d) = 0.37. It will also mean that the effect sizes de-
rived from the study will have good levels of precision for es-
timating the effect sizes in future studies and so provide
more accurate power analysis for such studies.
Discussion
This innovative study is, to our knowledge, the first to exam-
ine current risk communication practice in NHS Health
Check (using QRISK®2), the potential of using the JBS3 life-
time risk calculator, and to apply novel video-recording
methodological approaches in this context. The multi-fa-
ceted methodological approach has many advantages. First,
video-recordings will provide an objective and ‘real-time’ rec-
ord for quantitative and qualitative analysis of Health
Checks. Second, video-recorded Health Checks will allow
analysis of both verbal and non-verbal communication,
providing a comprehensive account, with the sensitivity to
capture subtle details [47]. Capturing nonverbal behaviour
can convey additional emotional information that is import-
ant in the study of practitioner-patient relationships [48].
Third, VSR interviews will enhance participant recall of
thoughts, perceptions and emotions during the consultation,
and allow a considered reflection on their related intentions
and actions [31].
The outcomes will have important implications. The
national NHS Health Check programme, which remains
one of only three mandatory functions included in the
2012 Health and Social Care Act and has political back-
ing as evidenced by inclusion in Living Well for Longer:
A call to action to reduce avoidable premature mortality
[49]. New insight from our data will inform recommen-
dations for which tool should be endorsed for Health
Checks and how practitioners should make best use of
them. However, in a period of growing budgetary pres-
sure, this work has value regardless of the future of NHS
Health Check as the need to effectively communicate
CVD risk and prompt positive behaviour change to pro-
tect against future disease will remain a key component
of primary care.
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